Search & Analyze

Lupin Ltd.

HealthcarePharmaceuticals & Drugs

www.lupin.com BSE: 500257NSE: LUPIN

₹2,105.00BSE0.99%

07 Sep, 4:01 PM

₹2,105.00

₹96.25K Cr

17.41

4.04

27.11%

₹2,132.45

₹2,096.00

₹2,530.00

₹1,900.30

Customise metrics bar

Price Performance

Peer Comparison

Name
SUN PHARMA. SUNPHARMA	1,899.80	37.69	4,55,825.66	0.84	2,901.23	26.53%	15,299.88	10.46%	19.11
DIVI'S LAB. DIVISLAB	9,305.00	84.45	2,47,018.51	0.32	902.00	65.50%	3,080.00	27.80%	21.51
TORRENT PHAR TORNTPHARM	4,913.00	85.68	1,86,874.73	0.77	566.00	3.28%	4,921.00	54.85%	19.27
ZYDUSLIFE ZYDUSLIFE	1,155.00	25.53	1,15,211.69	0.09	990.20	-34.90%	8,017.00	21.96%	21.39
CIPLA LTD. CIPLA	1,395.95	33.46	1,12,773.00	0.93	785.55	-39.18%	7,119.28	2.33%	16.00
LAURUSLABS LAURUSLABS	1,868.25	92.32	1,00,943.83	0.11	362.07	123.94%	2,026.31	29.10%	18.20
Lupin Ltd. LUPIN	2,105.00	17.41	96,254.46	0.86	1,416.98	16.01%	8,276.89	32.04%	28.86
MANKIND MANKIND	2,322.05	46.95	95,911.14	0.04	574.09	29.12%	4,030.59	12.89%	13.24

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	5,600.33	5,672.73	5,767.71	5,667.13	6,268.34	7,047.51	7,167.52	7,474.66	8,276.89
Expenses	4,359.36	4,332.37	4,411.81	4,345.96	4,541.10	4,706.18	4,905.67	4,989.08	5,827.34
	1,240.97	1,340.36	1,355.90	1,321.17	1,727.24	2,341.33	2,261.85	2,485.58	2,449.55
	22.16%	23.63%	23.51%	23.31%	27.55%	33.22%	31.56%	33.25%	29.60%
	67.78	42.29	53.71	56.95	79.04	90.00	-311.87	9.37	130.32
Interest	68.01	70.87	66.89	89.10	91.76	107.59	114.98	120.16	109.64
	247.71	256.92	271.45	393.18	298.98	316.77	312.96	446.79	452.85
	993.03	1,054.86	1,071.27	895.84	1,415.54	2,006.97	1,522.04	1,928.00	2,017.36
	18.88%	18.52%	19.83%	12.67%	13.71%	26.02%	22.44%	23.82%	29.76%
	801.31	852.63	855.16	772.52	1,219.03	1,477.92	1,175.55	1,460.34	1,415.00
	17.57	18.69	18.74	16.92	26.69	32.35	25.73	31.94	30.95

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
INCOME :
	29,676.39	28,445.90	31,737.49	37,186.93	43,111.99
	16,405.48	16,641.66	20,010.82	22,707.90	27,958.03
EXPENDITURE :
Increase/Decrease in Stock	-198.32	153.73	-457.44	-257.78	-162.45
Raw Material Consumed	5,979.16	5,870.16	6,102.10	6,075.96	6,488.04
Power & Fuel Cost	443.96	479.68	493.07	479.09	461.55
Employee Cost	2,989.30	3,087.15	3,494.57	3,964.20	4,574.53
Other Manufacturing Expenses	2,187.99	2,176.13	2,738.39	3,006.40	3,343.42
General and Administration Expenses	3,490.62	1,733.07	2,221.05	2,514.00	2,931.35
Selling and Distribution Expenses	1,096.10	1,188.72	1,343.30	1,417.19	1,853.97
Miscellaneous Expenses	201.43	232.45	286.67	231.32	308.09
	16,190.24	14,921.09	16,221.71	17,430.38	19,798.50
Operating Profit (Excl OI)	215.24	1,720.57	3,789.11	5,277.52	8,159.53
	213.67	150.91	141.58	201.61	1,080.92
	428.91	1,871.48	3,930.69	5,479.13	9,240.45
Interest	142.77	274.30	311.61	294.87	434.49
PBDT	286.14	1,597.18	3,619.08	5,184.26	8,805.96
	1,658.71	880.69	1,196.81	1,169.26	1,375.50
Profit Before Taxation & Exceptional Items	-1,372.57	716.49	2,422.27	4,015.00	7,430.46
Exceptional Income / Expenses					-557.91
	-1,372.21	716.49	2,422.27	4,015.00	6,872.55
Provision for Tax	137.15	268.80	486.70	708.74	1,517.08
	-1,509.36	447.69	1,935.57	3,306.26	5,355.47
Extra items				0.00	0.00
Minority Interest	-18.68	-17.61	-21.09	-24.64	-22.63
Consolidated Net Profit	-1,528.04	430.08	1,914.48	3,281.62	5,332.84
Profit Balance B/F	11,108.32	9,288.42	9,535.95	11,183.37	14,070.57
Appropriations	9,580.28	9,718.50	11,450.43	14,464.99	19,403.41
Equity Dividend %	200.00%	200.00%	400.00%	600.00%	900.00%
	-33.62	9.45	42.01	71.87	116.64
Adjusted EPS	-33.62	9.45	42.01	71.87	116.64

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
	90.90	91.00	91.14	91.32	91.44
Share Warrants & Outstandings	161.73	148.94	114.45	83.98	64.20
Total Reserves	11,900.64	12,224.56	14,084.70	17,028.20	22,292.63
Reserve excluding Revaluation Reserve	11,900.64	12,224.56	14,084.70	17,028.20	22,292.63
Revaluation reserve			0.00	0.00
	12,153.27	12,464.50	14,290.29	17,203.50	22,448.27
Minority Interest	68.71	78.32	83.16	90.85	65.10
Secured Loans	141.86			1,196.48	1,327.35
Unsecured Loans		27.51		569.75	316.04
Deferred Tax Assets / Liabilities	71.10	73.78	-56.66	-332.69	-345.95
Other Long Term Liabilities	607.12	547.77	500.96	520.42	805.36
Long Term Provisions	332.99	343.03	375.40	436.08	532.70
Total Non-Current Liabilities	1,153.07	992.09	819.70	2,390.04	2,635.50
Trade Payables	2,282.91	2,531.53	2,958.11	2,958.16	4,173.13
Other Current Liabilities	1,394.11	1,577.22	1,919.40	2,274.32	3,300.05
Short Term Borrowings	3,702.30	4,216.54	2,669.91	3,015.56	3,948.78
Short Term Provisions	897.12	940.08	954.08	713.35	1,229.28
Total Current Liabilities	8,276.44	9,265.37	8,501.50	8,961.39	12,651.24
Total Liabilities	21,651.49	22,800.28	23,694.65	28,645.78	37,800.11
Gross Block	15,990.30	18,077.42	19,664.69	20,183.69	23,217.39
Less: Accumulated Depreciation	8,608.68	9,722.18	10,653.98	10,464.34	12,137.78
Less: Impairment of Assets			132.41		85.73
Net Block	7,381.62	8,355.24	8,878.30	9,719.35	10,993.88
Capital Work in Progress	847.47	894.82	595.67	355.45	695.16
Non Current Investments	77.60	77.13	227.70	87.27	92.54
Long Term Investment	77.60	77.13	227.70	87.27	92.54
Long Term Loans & Advances	572.41	620.92	320.65	307.83	301.79
Other Non Current Assets	15.90	57.70	47.82	1,216.11	1,368.41
Total Non-Current Assets	9,193.81	10,348.98	10,247.00	11,847.20	13,772.73
Currents Investments	822.40	439.77	846.93	1,059.11	3,577.13
Inventories	4,630.73	4,491.76	4,953.90	5,476.35	6,083.25
Sundry Debtors	4,261.94	4,480.70	4,692.05	5,497.10	6,604.06
Cash and Bank	1,098.13	1,293.13	1,202.54	3,142.33	5,652.90
Other Current Assets	497.54	1,519.98	1,428.05	1,311.06	1,670.34
Short Term Loans and Advances	1,146.94	225.96	324.18	312.63	439.70
Total Current Assets	12,457.68	12,451.30	13,447.65	16,798.58	24,027.38
Net Current Assets (Including Current Investments)	4,181.24	3,185.93	4,946.15	7,837.19	11,376.14
Total Assets	21,651.49	22,800.28	23,694.65	28,645.78	37,800.11
Contingent Liabilities	668.79	943.93	860.70	780.83	1,094.02
Total Debt	3,844.16	4,244.05	2,669.91	5,076.65	5,910.20
	263.84	270.67	311.08	374.93	489.59
Adjusted Book Value	263.84	270.67	311.08	374.93	489.59

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)	FY 2025-26 (Mar)
No of Months	12.00	12.00	12.00	12.00	12.00
	-1,372.21	716.49	2,422.27	4,015.00	6,872.55
Adjustment	1,707.68	1,097.41	1,466.63	1,301.52	1,095.61
Changes In working Capital	-15.04	326.52	85.51	-1,410.54	633.69
Cash Flow after changes in Working Capital	320.43	2,140.42	3,974.41	3,905.98	8,601.85
Cash Flow from Operating Activities	367.31	1,897.24	3,648.36	2,999.94	7,334.50
Cash Flow from Investing Activities	1,292.23	-1,286.77	-1,712.20	-4,171.89	-3,864.59
Cash Flow from Financing Activitie	-1,572.32	-337.25	-2,184.21	1,731.88	-845.87
Net Cash Inflow / Outflow	87.22	273.22	-248.05	559.93	2,624.04
Opening Cash & Cash Equivalents	926.22	991.37	1,231.81	983.76	1,543.69
Closing Cash & Cash Equivalent	1,013.44	1,264.59	983.76	1,543.69	4,167.73

Ratios

Valuation

17.41

4.04

9.64

3.26

120.91

520.51

Profitability

27.11

28.86

16.12

18.93

12.42

Leverage & Liquidity

0.26

1.90

16.82

Returns

0.86

1.30

Shareholding Pattern

Numbers in percentages

Particulars	Jun '24	Sep '24	Dec '24	Mar '25	Jun '25	Sep '25	Dec '25	Mar '26	Jun '26
	46.98	46.96	46.95	46.92	46.90	46.90	46.89	46.86	46.85
	46.10	46.60	46.79	46.88	46.81	47.06	47.07	47.03	47.07
	6.92	6.44	6.26	6.20	6.28	6.06	6.03	6.11	6.08
	53.02	53.04	53.05	53.08	53.10	53.10	53.11	53.14	53.15
No. of Shareholders	2,88,537	2,79,280	2,81,988	2,83,210	2,86,604	2,80,256	2,88,931	2,90,411	3,00,283

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-07-22	Board Meeting	Quarterly Results
2026-07-08	AGM
2026-05-07	Ex Dividend	Rs.18.0000 per share(900%)Final Dividend	2026-07-17	2026-07-17

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)

No insider trading data available.

Sector Overview

HealthcarePharmaceuticals & Drugs

Lupin Ltd. operates in the Healthcare sector under the Pharmaceuticals & Drugs industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

11 members across the board and senior leadership

Amit Kumar Gupta

Company Secretary & Compliance Officer

—

Manju D Gupta

Chairperson

₹59.00 L

Mar '26

Nilesh Gupta

Managing Director

₹12.81 Cr

Mar '26

Ramesh Swaminathan

Executive Director, Global CFO, Head of IT and API Plus SBU

₹10.60 Cr

Mar '26

Jeffrey Kindler